• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病相关突变 LRRK2-G2019S 通过 NR2F1 改变多巴胺能分化动力学。

The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1.

机构信息

Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 4362 Belvaux, Luxembourg.

Department of Life Science and Medicine (DLSM), University of Luxembourg, 4362 Belvaux, Luxembourg.

出版信息

Cell Rep. 2021 Oct 19;37(3):109864. doi: 10.1016/j.celrep.2021.109864.

DOI:10.1016/j.celrep.2021.109864
PMID:34686322
Abstract

Increasing evidence suggests that neurodevelopmental alterations might contribute to increase the susceptibility to develop neurodegenerative diseases. We investigate the occurrence of developmental abnormalities in dopaminergic neurons in a model of Parkinson's disease (PD). We monitor the differentiation of human patient-specific neuroepithelial stem cells (NESCs) into dopaminergic neurons. Using high-throughput image analyses and single-cell RNA sequencing, we observe that the PD-associated LRRK2-G2019S mutation alters the initial phase of neuronal differentiation by accelerating cell-cycle exit with a concomitant increase in cell death. We identify the NESC-specific core regulatory circuit and a molecular mechanism underlying the observed phenotypes. The expression of NR2F1, a key transcription factor involved in neurogenesis, decreases in LRRK2-G2019S NESCs, neurons, and midbrain organoids compared to controls. We also observe accelerated dopaminergic differentiation in vivo in NR2F1-deficient mouse embryos. This suggests a pathogenic mechanism involving the LRRK2-G2019S mutation, where the dynamics of dopaminergic differentiation are modified via NR2F1.

摘要

越来越多的证据表明,神经发育异常可能导致易患神经退行性疾病。我们在帕金森病(PD)模型中研究多巴胺能神经元的发育异常。我们监测人源患者特异性神经上皮干细胞(NESCs)向多巴胺能神经元的分化。通过高通量图像分析和单细胞 RNA 测序,我们观察到 PD 相关的 LRRK2-G2019S 突变通过加速细胞周期退出并伴随细胞死亡增加来改变神经元分化的初始阶段。我们确定了 NESC 特异性核心调控回路和观察到的表型的分子机制。与对照组相比,LRRK2-G2019S NESCs、神经元和中脑类器官中参与神经发生的关键转录因子 NR2F1 的表达降低。我们还观察到 NR2F1 缺陷型小鼠胚胎中多巴胺能分化的加速。这表明存在一种涉及 LRRK2-G2019S 突变的致病机制,其中通过 NR2F1 来修饰多巴胺能分化的动力学。

相似文献

1
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1.帕金森病相关突变 LRRK2-G2019S 通过 NR2F1 改变多巴胺能分化动力学。
Cell Rep. 2021 Oct 19;37(3):109864. doi: 10.1016/j.celrep.2021.109864.
2
The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson's disease.LRRK2 G2019S 突变通过细胞外囊泡改变星形胶质细胞到神经元的通讯,并在帕金森病的人诱导多能干细胞衍生模型中诱导神经元萎缩。
Elife. 2021 Sep 30;10:e73062. doi: 10.7554/eLife.73062.
3
Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.帕金森病相关的G2019S LRRK2诱导的多巴胺能神经变性依赖于激酶和GTP酶活性。
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17296-17307. doi: 10.1073/pnas.1922184117. Epub 2020 Jul 6.
4
Non-cell autonomous mechanism of Parkinson's disease pathology caused by G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis.LRRK2 G2019S 突变导致的阿什肯纳兹犹太裔帕金森病患者的非细胞自主发病机制:单细胞分析。
Brain Res. 2019 Nov 1;1722:146342. doi: 10.1016/j.brainres.2019.146342. Epub 2019 Jul 19.
5
Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.帕金森病相关的富含亮氨酸重复激酶2(LRRK2)高活性激酶突变体破坏腹侧中脑神经元的突触小泡运输。
J Neurosci. 2017 Nov 22;37(47):11366-11376. doi: 10.1523/JNEUROSCI.0964-17.2017. Epub 2017 Oct 20.
6
Neural Stem Cells of Parkinson's Disease Patients Exhibit Aberrant Mitochondrial Morphology and Functionality.帕金森病患者的神经干细胞表现出异常的线粒体形态和功能。
Stem Cell Reports. 2019 May 14;12(5):878-889. doi: 10.1016/j.stemcr.2019.03.004. Epub 2019 Apr 11.
7
Impaired serine metabolism complements LRRK2-G2019S pathogenicity in PD patients.丝氨酸代谢障碍补充 LRRK2-G2019S 在 PD 患者中的致病性。
Parkinsonism Relat Disord. 2019 Oct;67:48-55. doi: 10.1016/j.parkreldis.2019.09.018. Epub 2019 Sep 19.
8
Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects.由 LRRK2 G2019S 诱导多能干细胞分化而来的多巴胺能神经元表现出早期神经突分支缺陷。
Sci Rep. 2016 Sep 19;6:33377. doi: 10.1038/srep33377.
9
In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson's Disease in Common Marmosets.体外 CRISPR/Cas9 指导的基因编辑构建 G2019S LRRK2 帕金森病模型的恒河猴
Sci Rep. 2020 Feb 26;10(1):3447. doi: 10.1038/s41598-020-60273-2.
10
Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.帕金森病相关的富含亮氨酸重复激酶2 G2019S错义突变在中脑多巴胺能神经元中的选择性表达会损害多巴胺释放及多巴胺能基因表达。
Hum Mol Genet. 2015 Sep 15;24(18):5299-312. doi: 10.1093/hmg/ddv249. Epub 2015 Jun 29.

引用本文的文献

1
Association of LRRK2 R1628P variant with Parkinson's disease in Kinh Vietnamese: a cross-sectional study.越南京族中LRRK2基因R1628P变异与帕金森病的关联:一项横断面研究。
Neurogenetics. 2025 Jul 31;26(1):56. doi: 10.1007/s10048-025-00840-9.
2
Dynamic gene regulatory network inference from single-cell data using optimal transport.利用最优传输从单细胞数据推断动态基因调控网络
Bioinformatics. 2025 Aug 2;41(8). doi: 10.1093/bioinformatics/btaf394.
3
Antioxidant, Osteogenic, and Neuroprotective Effects of Homotaurine in Aging and Parkinson's Disease Models.
同型牛磺酸在衰老和帕金森病模型中的抗氧化、成骨和神经保护作用
Antioxidants (Basel). 2025 Feb 21;14(3):249. doi: 10.3390/antiox14030249.
4
Transcriptome signatures of human neural stem cells derived from LRRK2 gene therapeutic cells.源自LRRK2基因治疗细胞的人类神经干细胞的转录组特征
Sci Rep. 2025 Apr 10;15(1):12286. doi: 10.1038/s41598-025-96884-w.
5
Human Midbrain Organoids Enriched With Dopaminergic Neurons for Long-Term Functional Evaluation.富含多巴胺能神经元的人类中脑类器官用于长期功能评估。
Cell Prolif. 2025 Jul;58(7):e70005. doi: 10.1111/cpr.70005. Epub 2025 Feb 20.
6
Potential Regulation of the Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript1 by Estrogen in Parkinson's Disease.雌激素对帕金森病中长链非编码RNA转移相关肺腺癌转录本1的潜在调控作用
Life (Basel). 2024 Dec 16;14(12):1662. doi: 10.3390/life14121662.
7
Experimental Cell Models for Investigating Neurodegenerative Diseases.用于研究神经退行性疾病的实验细胞模型。
Int J Mol Sci. 2024 Sep 9;25(17):9747. doi: 10.3390/ijms25179747.
8
How Parkinson's Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types.帕金森病相关 LRRK2 突变如何影响不同的中枢神经系统细胞类型。
J Parkinsons Dis. 2024;14(7):1331-1352. doi: 10.3233/JPD-230432.
9
Regulatory roles of N6-methyladenosine (mA) methylation in RNA processing and non-communicable diseases.N6-甲基腺苷(m6A)甲基化在 RNA 处理和非传染性疾病中的调控作用。
Cancer Gene Ther. 2024 Oct;31(10):1439-1453. doi: 10.1038/s41417-024-00789-1. Epub 2024 Jun 5.
10
Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.诱导多能干细胞和类器官在推进神经病理学研究和治疗中的应用。
Cells. 2024 Apr 25;13(9):745. doi: 10.3390/cells13090745.